References
- Peterson-KFF Health System Tracker. How does health spending in the U.S. compare to other countries?, 2023 Feb 9. Accessed at: https://www.healthsystemtracker.org/chart-collection/health-spending-u-s-compare-countries/#GDP%20per%20capita%20and%20health%20consumption%20spending%20per%20capita,%202021%20(U.S.%20dollars,%20PPP%20adjusted)
- National Center for Health Statistics, Centers for Disease Control and Prevention. Mortality in the United States, 2021. 2022 Sep. Accessed at: https://www.cdc.gov/nchs/data/databriefs/db456.pdf
- The World Bank. Life expectancy at birth, total (years), United States. Sep 2023 Accessed at: https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=US&most_recent_value_desc=true
- Public Law 92-484. U.S. Congress. The technology assessment act of 1972. Oct 2023 Accessed at: https://www.govinfo.gov/content/pkg/STATUTE-86/pdf/STATUTE-86-Pg797.pdf
- Blair PD. Effective science and technology assessment advice for congress: comparing options. Sci Public Policy. 2021;48(2):164–176. doi: 10.1093/scipol/scaa070
- Banta D, Behney CJ. Office of technology assessment health program. Int J Technol Assess Health Care. 2009 Jul;25(1):28–32. doi: 10.1017/S0266462309090382
- Introduction to the EUR-ASSESS report. Int J Technol Assess Health Care. 1997 Spring;13(2):133–143. 10.1017/S0266462300010345
- Smith RJ. OTA study Highlights star wars difficulties. Science. 1985 Oct 4;230(4721):50. doi: 10.1126/science.230.4721.50.a
- Perry S. Special report. The brief life of the National Center for health care technology. N Engl J Med. 1982 Oct 21;307(17):1095–1100. doi: 10.1056/NEJM198210213071738
- Neumann PJ, Cohen JT, Ollendorf DA. The right price: a value-based prescription for drug costs. (NY): Oxford University Press; 2021.
- Neumann PJ, Rosen AB, Weinstein MC. Medicare and cost-effectiveness analysis. N Engl J Med. 2005 Oct 6;353(14):1516–1522. doi: 10.1056/NEJMsb050564
- D’Arcy LP, Rich EC. From comparative effectiveness research to patient-centered outcomes research: policy history and future directions. Neurosurg Focus. 2012 Jul;33(1):E7. doi: 10.3171/2012.4.FOCUS12106
- Cohen JT, Neumann PJ, Ollendorf DA The much-maligned ‘quality-adjusted life year’ is a vital tool for health care policy. STAT First Opinion. Sep 2023 Mar 22, 2023. Accessed at: https://www.statnews.com/2023/03/22/the-much-maligned-quality-adjusted-life-year-is-a-vital-tool-for-health-care-policy/
- Peterson Foundation PG. Healthcare reform. Sep 2023 Accessed at: https://www.pgpf.org/finding-solutions/healthcare
- Institute for Clinical and Economic Review. History and impact. Oct 2023 Accessed at: https://icer.org/who-we-are/history-impact/
- Cubanski J, Neuman T, Freed M Explaining the prescription drug provisions in the inflation reduction act. Kaiser Family Foundation. Sep 2023 Jan 24, 2023. Accessed at: https://www.kff.org/medicare/issue-brief/explaining-the-prescription-drug-provisions-in-the-inflation-reduction-act/.
- H.R.5376: inflation reduction act of 2022. Congress.Gov. Oct 2023 Accessed at: https://www.congress.gov/bill/117th-congress/house-bill/5376/text/rh
- Lakdawalla D, Neumann PJ, Wilensky GR, et al. Health technology assessment in the U.S. – a vision for the future. Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California; 2023 Sep Feb 9, 2021. Accessed at: https://healthpolicy.usc.edu/research/health-technology-assessment-in-the-u-s-a-vision-for-the-future/